We are seeking applicants for a 2-year postdoctoral position in Daniel Otzen’s research group at iNANO.

Expected start date and duration of employment

September 1 2026 or as soon as possible thereafter.

Job description

You will be working with antibodies targeting α-synuclein aggregates for therapy against Parkinson’s Disease. The antibodies will be engineered for optimal target engagement. The work involves a close collaboration with PI Dr. Simon Glerup (CSO, Draupnir Bio ApS) and Assoc. Prof. Nathalie Van Den Berge (Dept. of Clinical Medicine, Aarhus University).

Your profile

Applicants should hold a PhD within antibody expression, production and/or engineering. Experience with protein aggregation is an added advantage but not critical. You are expected to be interested in both fundamental and translational science and to enjoy working in the interface between academia and indu...